Company / Profit Margin
Xenetic Biosciences, Inc. Profit Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-158.4%
FY2025
5-year range
-2493.1% / -158.4%
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 5 consecutive years, from -74856.6% in FY2020 to -158.4% in FY2025.
Based on SEC 10-K filings.
-158.4% in FY2025 with a 5-year CAGR of +74698.2%.
Improved from -383.9% to -158.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +328.0pp
- 5-Year Change
- +74698.2pp
- 10-Year Change
- -
Key checks
Key Insights
- Xenetic Biosciences, Inc.'s profit margin has grown for 5 consecutive years.
- In FY2025, profit margin increased 2.7% year-over-year.
- Peak profit margin was recorded in FY2018.
- Lowest profit margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -158.4% | +2.7% |
| FY2024 | -162.8% | +57.6% |
| FY2023 | -383.9% | +21.1% |
| FY2022 | -486.4% | +80.5% |
| FY2021 | -2493.1% | +96.7% |
| FY2020 | -74856.6% | - |
| FY2019 | - | - |
| FY2018 | -47.4% | +97.4% |
| FY2017 | -1806.9% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026